German Cancer Research Center (DKFZ) at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
German Cancer Research Center (DKFZ) brings 6 presentations to ESGCT 2026 in Hamburg. Its work centres on non-viral DNA nanovectors for engineering immune cells, including delivery by mechanoporation and sequences that improve nuclear uptake. Other strands cover oncolytic viruses with inducible payloads and mRNA approaches to reshape the tumour microenvironment.
| Organization | ESGCT 2026 Attendance |
|---|---|
German Cancer Research Center (DKFZ) Heidelberg, Germany | |
Germany's national cancer research centre, with programs in oncolytic viruses and cancer immunotherapy. | Talk Wed Oct 28 9:00am–10:30am Oncolytic Virus Development: Personalized Approaches and Inducible Payloads Cancer gene and cell therapy Poster Wed Oct 28 1:30pm–3:30pm Beyond electroporation: mechanoporation enables non-viral delivery of episomal SMAR nanovectors into immune cells Poster Wed Oct 28 1:30pm–3:30pm Developing DNA targeting sequences for enhanced nuclear delivery of episomal SMAR nanovectors Poster Wed Oct 28 1:30pm–3:30pm Persistent genetic modification of NK cells using non-viral SMAR DNA vectors for cancer immunotherapy Poster Wed Oct 28 1:30pm–3:30pm Rational Design of High-Capacity Episomal DNA NanoVectors for Advanced Immune Cell Engineering Poster Wed Oct 28 1:30pm–3:30pm mRNA-Based Strategies for Tumor Microenvironment Modulation to Enhance Anti-Tumor Immunity |
Instantly find 20 buyers from German Cancer Research Center (DKFZ)
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction